Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. (Q51918187)
Jump to navigation
Jump to search
scientific article published in April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. |
scientific article published in April 2006 |
Statements
1 reference
Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. (English)
1 reference
Christoph U Correll
1 reference
John M Kane
1 reference
Anne M Frederickson
1 reference
Peter Manu
1 reference
1 April 2006
1 reference
67
1 reference
4
1 reference
575-583
1 reference
Identifiers
1 reference